Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets 2020-07-21 21:13
Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon 2020-07-21 10:13
China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor 2020-07-20 22:39
JW Therapeutics Acquires Syracuse Biopharma and Its in-Licenses With Eureka Therapeutics' Solid Tumor Technologies in China 2020-07-20 21:33
Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis 2020-07-20 20:00
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization 2020-07-20 08:00
New Early Breast Cancer Drug Now Approved in Malaysia 2020-07-17 06:16
Harbour BioMed Presented Pre-Clinical Data on A Fully Human Anti-CD73 Antibody at AACR Virtual Annual Meeting 2020-07-16 18:00
I-Mab Announces Authorization of Stock Repurchase Program up to $20 Million 2020-07-16 04:15
Ascentage Pharma's Bcl-2 Inhibitor APG-2575 Granted Orphan Drug Designation by the FDA for the Treatment of Waldenström Macroglobulinemia 2020-07-15 21:07
Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement 2020-07-15 13:46
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA 2020-07-14 20:00
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia 2020-07-14 18:00
Zuellig Pharma appoints John Graham as new CEO 2020-07-14 09:00
Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models 2020-07-14 01:55
PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19 2020-07-13 16:00
AVATAMED Partners CBmed in Europe on Precision Cancer Project 2020-07-13 15:16
SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent 2020-07-13 15:00
Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit 2020-07-13 12:25
Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development 2020-07-13 06:00
1 288 289 290 291 292 412